OptimizeRx Corp.

OPRX Healthcare Health Information Services

OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue fell 29.8%, EPS fell 150.0%, free cash flow grew 89.9% and total debt fell 33.1%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

8.50 0.35 −3.95%
Market cap
$166.7M
P/E
35.4×
Fwd P/E
23.0×
Dividend yield
—
F-score
8/9
Altman Z
3.31
Beneish M
−2.77
Dividend safety
n/a

OptimizeRx Corp. (OPRX) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, OptimizeRx Corp. (OPRX) trades at a P/E ratio of 35.4×. Over the past ten years it has ranged from 0.0× (December 2025) to 25,457× (November 2018); the current reading is higher than 82% of that period. That is below the Health Information Services industry median of 39.8× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 45.4× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 2,736× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 530× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 23.8× 36.62%
Mar 2026 17.4× (61.58%)
Dec 2025 45.4× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 25,457×
Ten-year median 0.0×
Current reading's percentile 82

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on OPRX